본문 바로가기
KERD
논문KCI 등재

Understanding the Pathogenesis of Zika Virus Infection Using Animal Models

Mukesh Kumar|신옥|Keeton K. Krause|Francine Azouz
대한면역학회 (The Korean Association of Immunologists)|2017.10|Immune Network|제17권 제5호|pp. 287-297|DOI https://doi.org/10.4110/in.2017.17.5.287

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

EtiologyAnimal modelZika virus

초록

Zika virus (ZIKV) is a member of Flaviviridae family that has emerged as a pathogen of significant public health importance. The rapid expansion of ZIKV in the South and Central America has recently gained medical attention emphasizing the capacity of ZIKV to spread to non-endemic regions. ZIKV infection during pregnancy has been demonstrated to cause microcephaly and other fetal developmental abnormalities. An increased incidence of Guillain-Barre syndrome, an immune mediated neuropathy of the peripheral nervous system, has also been reported in ZIKV-infected patients in French Polynesia and Brazil. No effective therapies currently exist for treating patients infected with ZIKV. Despite the relatively short time interval, an intensive effort by the global scientific community has resulted in development of animal models to study multiple aspects of ZIKV biology. Several animal models have been established to investigate pathogenesis of ZIKV in adults, pregnant mothers, and developing fetuses. Here we review the remarkable progress of newly developed small and large animal models for understanding ZIKV pathogenesis.

Abstract

Zika virus (ZIKV) is a member of Flaviviridae family that has emerged as a pathogen of significant public health importance. The rapid expansion of ZIKV in the South and Central America has recently gained medical attention emphasizing the capacity of ZIKV to spread to non-endemic regions. ZIKV infection during pregnancy has been demonstrated to cause microcephaly and other fetal developmental abnormalities. An increased incidence of Guillain-Barre syndrome, an immune mediated neuropathy of the peripheral nervous system, has also been reported in ZIKV-infected patients in French Polynesia and Brazil. No effective therapies currently exist for treating patients infected with ZIKV. Despite the relatively short time interval, an intensive effort by the global scientific community has resulted in development of animal models to study multiple aspects of ZIKV biology. Several animal models have been established to investigate pathogenesis of ZIKV in adults, pregnant mothers, and developing fetuses. Here we review the remarkable progress of newly developed small and large animal models for understanding ZIKV pathogenesis.

참고문헌 (78)

  1. Musso D, "Zika virus", Clin Microbiol Rev, 29, pp.487~524 (2016)
  2. Klase ZA, "Zika fetal neuropathogenesis: etiology of a viral syndrome", PLoS Negl Trop Dis, 10, pp.e0004877~ (2016)
  3. Culjat M, "Clinical and imaging findings in an infant with Zika embryopathy", Clin Infect Dis, 63, pp.805~811 (2016)
  4. Kumar M, "Prevalence of antibodies to Zika virus in mothers from Hawaii who delivered babies with and without microcephaly between 2009–2012", PLoS Negl Trop Dis, 10, pp.e0005262~ (2016)
  5. Walker WL, "Zika virus disease cases - 50 states and the district of Columbia, January 1–July 31, 2016", MMWR Morb Mortal Wkly Rep, 65, pp.983~986 (2016)
  6. Likos A, "Local mosquito-borne transmission of Zika virus - Miami-Dade and Broward Counties, Florida, June–August 2016", MMWR Morb Mortal Wkly Rep, 65, pp.1032~1038 (2016)
  7. Adams L, "Update: ongoing Zika virus transmission - Puerto Rico, November 1, 2015–July 7, 2016", MMWR Morb Mortal Wkly Rep, 65, pp.774~779 (2016)
  8. Mlakar J, "Zika virus associated with microcephaly", N Engl J Med, 374, pp.951~958 (2016)
  9. D’Ortenzio E, "Evidence of sexual transmission of Zika virus", N Engl J Med, 374, pp.2195~2198 (2016)
  10. Russell K, "Male-to-female sexual transmission of Zika virus-United States, January–April 2016", Clin Infect Dis, 64, pp.211~213 (2017)
  11. Ferguson NM, "Epidemiology. Countering the Zika epidemic in Latin America", Science, 353, pp.353~354 (2016)
  12. Oster AM, "Update: interim guidance for prevention of sexual transmission of Zika virus--United States, 2016", MMWR Morb Mortal Wkly Rep, 65, pp.323~325 (2016)
  13. Faria NR, "Zika virus in the Americas: early epidemiological and genetic findings", Science, 352, pp.345~349 (2016)
  14. Herrera BB, "Continued transmission of Zika virus in humans in West Africa, 1992–2016", J Infect Dis, 215, pp.1546~1550 (2017)
  15. Grard G, "Zika virus in Gabon (Central Africa)--2007: a new threat from Aedes albopictus?", PLoS Negl Trop Dis, 8, pp.e2681~ (2014)
  16. Fagbami AH., "Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State", J Hyg (Lond), 83, pp.213~219 (1979)
  17. Saluzzo JF, "Serological survey for arbovirus antibodies in the human and simian populations of the South-East of Gabon (author's transl)", Bull Soc Pathol Exot Filiales, 75, pp.262~266 (1982)
  18. Musso D, "Emergence of Zika virus: where does it come from and where is it going to?", Lancet Infect Dis, 17, pp.255~ (2017)
  19. "WHO supports Cabo Verde in managing Zika virus", Saudi Med J, 37, pp.470~471 (2016)
  20. Hennessey M, "Zika virus spreads to new areas - region of the Americas, May 2015–January 2016", MMWR Morb Mortal Wkly Rep, 65, pp.55~58 (2016)
  21. Zmurko J, "The viral polymerase inhibitor 7-Deaza-2'-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model", PLoS Negl Trop Dis, 10, pp.e0004695~ (2016)
  22. Sacramento CQ, "The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication", Sci Rep, 7, pp.40920~ (2017)
  23. Reznik SE, "Sofosbuvir: an antiviral drug with potential efficacy against Zika infection", Int J Infect Dis, 55, pp.29~30 (2017)
  24. Bullard-Feibelman KM, "The FDA-approved drug sofosbuvir inhibits Zika virus infection", Antiviral Res, 137, pp.134~140 (2017)
  25. Julander JG, "Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model", Antiviral Res, 137, pp.14~22 (2017)
  26. Mariana Baz, "In vitro susceptibility of geographically and temporally distinct zika viruses to favipiravir and ribavirin", Antiviral Therapy, 22(7), pp.613~618 (2017), International Medical Press[DOI]
  27. Cai L, "Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication", Arch Virol, 162, pp.2847~2853 (2017)
  28. Best K, "Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies", Proc Natl Acad Sci U S A, 114, pp.8847~8852 (2017)
  29. Lanko K, "Replication of the Zika virus in different iPSC-derived neuronal cells and implications to assess efficacy of antivirals", Antiviral Res, 145, pp.82~86 (2017)
  30. Furuta Y, "Favipiravir (T-705), a novel viral RNA polymerase inhibitor", Antiviral Res, 100, pp.446~454 (2013)
  31. Furuta Y, "T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections", Antiviral Res, 82, pp.95~102 (2009)
  32. Furuta Y, "In vitro and in vivo activities of anti-influenza virus compound T-705", Antimicrob Agents Chemother, 46, pp.977~981 (2002)
  33. Hsiao-Han Lin, "Zika virus structural biology and progress in vaccine development", Biotechnology Advances (2017), Elsevier BV[DOI]
  34. Larocca RA, "Vaccine protection against Zika virus from Brazil", Nature, 536, pp.474~478 (2016)
  35. Abbink P, "Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys", Science, 353, pp.1129~1132 (2016)
  36. Griffin BD, "DNA vaccination protects mice against Zika virus-induced damage to the testes", Nat Commun, 8, pp.15743~ (2017)
  37. Dick GW., "Zika virus. II. Pathogenicity and physical properties", Trans R Soc Trop Med Hyg, 46, pp.521~534 (1952)
  38. Bell TM, "Zika virus infection of the central nervous system of mice", Arch Gesamte Virusforsch, 35, pp.183~193 (1971)
  39. Way JH, "Comparative studies of some African arboviruses in cell culture and in mice", J Gen Virol, 30, pp.123~130 (1976)
  40. Dick GW, "Zika virus. I. Isolations and serological specificity", Trans R Soc Trop Med Hyg, 46, pp.509~520 (1952)
  41. Lazear HM, "A mouse model of Zika virus pathogenesis", Cell Host Microbe, 19, pp.720~730 (2016)
  42. Rossi SL, "Characterization of a novel murine model to study Zika virus", Am J Trop Med Hyg, 94, pp.1362~1369 (2016)
  43. Morrison TE, "Animal models of Zika virus infection, pathogenesis, and immunity", J Virol, 91, pp.e00009~e00017 (2017)
  44. Miner JJ, "Zika virus infection during pregnancy in mice causes placental damage and fetal demise", Cell, 165, pp.1081~1091 (2016)
  45. Cugola FR, "The Brazilian Zika virus strain causes birth defects in experimental models", Nature, 534, pp.267~271 (2016)
  46. Grant A, "Zika virus targets human STAT2 to inhibit Type I interferon signaling", Cell Host Microbe, 19, pp.882~890 (2016)
  47. Bowen JR, "Zika virus antagonizes Type I interferon responses during infection of human dendritic cells", PLoS Pathog, 13, pp.e1006164~ (2017)
  48. Manangeeswaran M, "Zika (PRVABC59) infection is associated with T cell Infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl", 6 mice, 2016, pp.12, e1006004~
  49. Fernandes NC, "Experimental Zika virus infection induces spinal cord injury and encephalitis in newborn Swiss mice", Exp Toxicol Pathol, 69, pp.63~71 (2017)
  50. Haller O, "The interferon response circuit: induction and suppression by pathogenic viruses", Virology, 344, pp.119~130 (2006)
  51. Suthar MS, "West Nile virus infection and immunity", Nat Rev Microbiol, 11, pp.115~128 (2013)
  52. Schoenborn JR, "Regulation of interferon-gamma during innate and adaptive immune responses", Adv Immunol, 96, pp.41~101 (2007)
  53. Dowall SD, "A susceptible mouse model for Zika virus infection", PLoS Negl Trop Dis, 10, pp.e0004658~ (2016)
  54. Li H, "Zika virus infects neural progenitors in the adult mouse brain and alters proliferation", Cell Stem Cell, 19, pp.593~598 (2016)
  55. Miner JJ, "Zika virus infection in mice causes panuveitis with shedding of virus in tears", Cell Rep, 16, pp.3208~3218 (2016)
  56. Aliota MT, "Characterization of lethal Zika virus infection in AG129 mice", PLoS Negl Trop Dis, 10, pp.e0004682~ (2016)
  57. Tripathi S, "A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses", PLoS Pathog, 13, pp.e1006258~ (2017)
  58. Govero J, "Zika virus infection damages the testes in mice", Nature, 540, pp.438~442 (2016)
  59. Ma W, "Zika virus causes testis damage and leads to male infertility in mice", Cell, 167, pp.1511.e10~1524.e10 (2016)
  60. Yockey LJ, "Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection", Cell, 166, pp.1247.e4~1256.e4 (2016)
  61. Tang WW, "A mouse model of Zika Virus sexual transmission and vaginal viral replication", Cell Rep, 17, pp.3091~3098 (2016)
  62. Deng YQ, "Adenosine analog NITD008 is a potent inhibitor of Zika virus", Open Forum Infect Dis, 3, pp.ofw175~ (2016)
  63. Zhao H, "Structural basis of Zika virus-specific antibody protection", Cell, 166, pp.1016~1027 (2016)
  64. Swanstrom JA, "Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus", MBio, 7, pp.e01123~e01116 (2016)
  65. Sapparapu G, "Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice", Nature, 540, pp.443~447 (2016)
  66. Smith DR, "Neuropathogenesis of Zika virus in a highly susceptible immunocompetent mouse model after antibody blockade of Type I interferon", PLoS Negl Trop Dis, 11, pp.e0005296~ (2017)
  67. Kumar M, "A Guinea pig model of Zika virus infection", Virol J, 14, pp.75~ (2017)
  68. Mess A., "The Guinea pig placenta: model of placental growth dynamics", Placenta, 28, pp.812~815 (2007)
  69. Padilla-Carlin DJ, "The Guinea pig as a model of infectious diseases", Comp Med, 58, pp.324~340 (2008)
  70. Dudley DM, "A rhesus macaque model of Asian-lineage Zika virus infection", Nat Commun, 7, pp.12204~ (2016)
  71. Li XF, "Characterization of a 2016 clinical isolate of Zika virus in non-human primates", EBioMedicine, 12, pp.170~177 (2016)
  72. Nguyen SM, "Highly efficient maternal-fetal Zika virus transmission in pregnant rhesus macaques", PLoS Pathog, 13, pp.e1006378~ (2017)
  73. Aliota MT, "Heterologous protection against Asian Zika virus challenge in rhesus macaques", PLoS Negl Trop Dis, 10, pp.e0005168~ (2016)
  74. Osuna CE, "Zika viral dynamics and shedding in rhesus and cynomolgus macaques", Nat Med, 22, pp.1448~1455 (2016)
  75. Koide F, "Development of a Zika virus infection model in cynomolgus macaques", Front Microbiol, 7, pp.2028~ (2016)
  76. Driggers RW, "Zika virus infection with prolonged maternal viremia and fetal brain abnormalities", N Engl J Med, 374, pp.2142~2151 (2016)
  77. Adams Waldorf KM, "Fetal brain lesions after subcutaneous inoculation of Zika virus in a pregnant nonhuman primate", Nat Med, 22, pp.1256~1259 (2016)
  78. Dowd KA, "Rapid development of a DNA vaccine for Zika virus", Science, 354, pp.237~240 (2016)

관련 논문AI추천

An Update on Zika Virus in Asia윤인규, 임경아, 임슬기대한감염학회 · Infection and Chemotherapy2017 · 제49권 제2호Zika: what we do and do not know based on the experiences of BrazilCristina Possas한국역학회 · Epidemiology and Health2016 · 제38권 The current status of Zika virus in Southeast AsiaViroj Wiwanitkit한국역학회 · Epidemiology and Health2016 · 제38권 Experimental Animal Models of Coronavirus Infections: Strengths and Limitations최영기, Casel Mark Anthony B., Rollon Rare G.대한면역학회 · Immune Network2021 · 제21권 제2호Zika Virus Impairs Host NLRP3-mediated Inflammasome Activation in an NS3-dependent Manner신옥, 김은지, 심도완, 유제욱, 황인화대한면역학회 · Immune Network2019 · 제19권 제6호Zika Virus Proteins NS2A and NS4A Are Major Antagonists that Reduce IFN-β Promoter Activity Induced by the MDA5/RIG-I Signaling Pathway김성준, 명진종, 이정윤, Nguyen Thi Thuy Ngan한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2019 · 제29권 제10호

이 간행물의 다른 논문 (8건)

Immune Network Selected for Science Citation Index Expanded이종길pp. 275-275IL-17A-Producing Foxp3+ Regulatory T Cells and Human Diseases정민경, 곽정은, 신의철pp. 276-286Current Understanding in Neutrophil Differentiation and Heterogeneity홍장원pp. 298-306Semi-Functional Quantitative Flow Cytometry Assay for Lymphocytic Choriomeningitis Virus Titration반영호, 하상준pp. 307-316Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients신의철, 김영훈, 김태은, 김선미, 김성한, 한덕종, 성흥섭, 신성, 권지수pp. 317-325
원문 보기